A
Armando Calvo
Publications - 1
Citations - 728
Armando Calvo is an academic researcher. The author has contributed to research in topics: Tocilizumab & Rheumatoid arthritis. The author has an hindex of 1, co-authored 1 publications receiving 693 citations.
Papers
More filters
Journal ArticleDOI
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study
Graeme Jones,Anthony Sebba,Jieruo Gu,Mitchell B. Lowenstein,Armando Calvo,Juan J. Gomez-Reino,Daniel Siri,Matija Tomšič,Emma Alecock,Thasia G. Woodworth,Mark C. Genovese +10 more
TL;DR: Tocilizumab monotherapy is better than methotrexate monotherapy, with rapid improvement in RA signs and symptoms, and a favourable benefit–risk, in patients for whom treatment with methotRexate or biological agents has not previously failed.